上海璎黎药业有限公司

Country

Ownership: -

Established: 2011-01-31

Employees: -

Market Cap: -

Website: http://www.yl-pharma.com

Clinical Trials

0

Active:0

Completed:0

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Linperlisib Tablets

Product Name: 因他瑞

Approval Number: 国药准字H20220030

Approval Date: Nov 8, 2022

NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.